Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pantelis Vlachos"'
Autor:
V. Chyrok, Kim A. Papp, Jana Hercogová, Pantelis Vlachos, Martin Ullmann, Christopher J Edwards
Publikováno v:
British Journal of Dermatology. 182:316-326
Background MSB11022 is a proposed adalimumab biosimilar. Objectives To compare the efficacy, safety and immunogenicity of MSB11022 with reference adalimumab. Methods AURIEL-PsO was a double-blind randomized controlled equivalence trial, in which pati
Autor:
Martin Ullmann, Veranika Chyrok, Pantelis Vlachos, Christopher J Edwards, Vishal Ghori, Joëlle Monnet
Publikováno v:
Clinical rheumatology. 38(12)
To compare the safety, efficacy, and immunogenicity of MSB11022 (acetate-buffered formulation), an adalimumab biosimilar, with the reference product.AURIEL-RA study was a phase 3, multicenter, randomized, double-blind, parallel group trial (NCT030523
Publikováno v:
Poster Presentations.
Background: Adalimumab is a fully human anti-TNF monoclonal antibody indicated for the treatment of multiple inflammatory disorders, including rheumatoid arthritis (RA). MSB11022 is a proposed adalimumab biosimilar that has been shown to be structura
Autor:
Volker Wagner, Pantelis Vlachos, Neil Attkins, Sanjeev Roy, Martin Ullmann, Tim Mant, Elizabeth Hyland
Publikováno v:
British Journal of Clinical Pharmacology
Aims The aim of the study was to compare the pharmacokinetics (PK), safety and tolerability of the proposed adalimumab biosimilar MSB11022 (Merck) with Humira® (AbbVie), sourced from both the US (US reference product [US-RP]) and Europe (European re
Autor:
Jana Hercogová, Kim A. Papp, Martin Ullmann, Pantelis Vlachos, Christopher J Edwards, T. Halady, V. Chyrok
Publikováno v:
Psoriatic arthritis.
Background: Adalimumab is a fully human anti-TNF mAb, indicated for the treatment of multiple inflammatory disorders. MSB11022 is a proposed adalimumab biosimilar that has shown analytical similarity [1] and bioequivalence to US-licensed and EU-appro
Autor:
Martin Ullmann, Kim A. Papp, S. Naeyaert, Pantelis Vlachos, Christopher J Edwards, Jana Hercogová, V. Chyrok
Publikováno v:
Value in Health. 22:S53-S54
Publikováno v:
Journal of Business and Technical Communication. 18:361-402
This article introduces an IText system the authors built to enhance student practice in language awareness within commonly taught written genres (e.g., self-portraits, profiles, scenic writing, narratives, instructions, and arguments). The system pr
Publikováno v:
Computers and the Humanities. 38:15-36
In author attribution studies function words or lexical measures areoften used to differentiate the authors' textual fingerprints. Thesestudies can be thought of as quantifying the texts, representing thetext with measured variables that stand for sp
Autor:
Pantelis Vlachos, Alan E. Gelfand
Publikováno v:
Journal of Statistical Planning and Inference. 111:223-234
Model choice is a fundamental problem in data analysis. With interest in hierarchical models which typically arise as Bayesian specifications, we confine ourselves to Bayesian model choice criteria. If Y denotes the observed data and T( Y ) is the cr
Autor:
Pantelis Vlachos, Joseph B. Kadane
Publikováno v:
Statistics and Computing. 12:147-152
Optimal batch-sequential designs are difficult to compute, even when sufficient statistics and relatively uncomplicated loss functions simplify the calculations required. While backward induction applies, its difficulty grows exponentially in the num